This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheeran, M. C.-J.
Right arrow Articles by Schleiss, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheeran, M. C.-J.
Right arrow Articles by Schleiss, M. R.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, January 2009, p. 99-126, Vol. 22, No. 1
0893-8512/09/$08.00+0     doi:10.1128/CMR.00023-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Neuropathogenesis of Congenital Cytomegalovirus Infection: Disease Mechanisms and Prospects for Intervention

Maxim C.-J. Cheeran,1 James R. Lokensgard,1 and Mark R. Schleiss2*

Center for Infectious Diseases and Microbiology Translational Research, Departments of Medicine,1 Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota2

Congenital cytomegalovirus (CMV) infection is the leading infectious cause of mental retardation and hearing loss in the developed world. In recent years, there has been an improved understanding of the epidemiology, pathogenesis, and long-term disabilities associated with CMV infection. In this review, current concepts regarding the pathogenesis of neurological injury caused by CMV infections acquired by the developing fetus are summarized. The pathogenesis of CMV-induced disabilities is considered in the context of the epidemiology of CMV infection in pregnant women and newborn infants, and the clinical manifestations of brain injury are reviewed. The prospects for intervention, including antiviral therapies and vaccines, are summarized. Priorities for future research are suggested to improve the understanding of this common and disabling illness of infancy.


* Corresponding author. Mailing address: CIDMTR, 3-222 TRF, 2001 6th Street, S.E., Minneapolis, MN 55455. Phone: (612) 626-9913. Fax: (612) 626-9924. E-mail: schleiss{at}umn.edu


Clinical Microbiology Reviews, January 2009, p. 99-126, Vol. 22, No. 1
0893-8512/09/$08.00+0     doi:10.1128/CMR.00023-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.